EUVIMEDEUVIMED entdecken
Crossref

Percutaneous ultrasound and endoscopic ultrasound-guided biopsy of solid pancreatic lesions: An analysis of 1074 lesions

Wei-Lu Chai, Xiu-Feng Kuang, Li Yu, Chao Cheng, Xin-Yan Jin, Qi-Yu Zhao, Tian-An Jiang

Hepatobiliary & Pancreatic Diseases International · 2023-06 · 22 (3) · 302-309

DOI: 10.1016/j.hbpd.2022.06.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatobiliary & Pancreatic Diseases International, 2023-06. Verfasst von Wei-Lu Chai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasonography, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Department of Hepatobil…. Hauptthemen laut MEDLINE: Pancreatic Diseases, Pancreatic Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUNDS: Percutaneous ultrasound (US) and endoscopic ultrasound (EUS)-guided pancreatic biopsies are widely accepted in the diagnosis of pancreatic diseases. Studies comparing the diagnostic performance of US- and EUS-guided pancreatic biopsies are lacking. This study aimed to evaluate and compare the diagnostic yields of US- and EUS-guided pancreatic biopsies and identify the risk factors for inconclusive biopsies. METHODS: Of the 1074 solid pancreatic lesions diagnosed from January 2017 to February 2021 in our center, 275 underwent EUS-guided fine needle aspiration (EUS-FNA), and 799 underwent US-guided core needle biopsy (US-CNB/FNA). The outcomes were inconclusive pathological biopsy, diagnostic accuracy and the need for repeat biopsy. All of the included factors and diagnostic performances of both US-CNB/FNA and EUS-FNA were compared, and the independent predictors for the study outcomes were identified. RESULTS: The diagnostic accuracy was 89.8% for EUS-FNA and 95.2% for US-CNB/FNA (P = 0.001). Biopsy under EUS guidance [odds ratio (OR) = 1.808, 95% confidence interval (CI): 1.083-3.019; P = 0.024], lesion size < 2 cm (OR = 2.069, 95% CI: 1.145-3.737; P = 0.016), hypoechoic appearance (OR = 0.274, 95% CI: 0.097-0.775; P = 0.015) and non-pancreatic ductal adenocarcinoma carcinoma (PDAC) diagnosis (OR = 2.637, 95% CI: 1.563-4.449; P < 0.001) were identified as factors associated with inconclusive pathological biopsy. Hypoechoic appearance (OR = 0.236, 95% CI: 0.064-0.869; P = 0.030), lesions in the uncinate process of the pancreas (OR = 3.506, 95% CI: 1.831-6.713; P < 0.001) and non-PDAC diagnosis (OR = 2.622, 95% CI: 1.278-5.377; P = 0.009) were independent predictors for repeat biopsy. Biopsy under EUS guidance (OR = 2.024, 95% CI: 1.195-3.429; P = 0.009), lesions in the uncinate process of the pancreas (OR = 1.776, 95% CI: 1.014-3.108; P = 0.044) and hypoechoic appearance (OR = 0.127, 95% CI: 0.047-0.347; P < 0.001) were associated with diagnostic accuracy. CONCLUSIONS: In conclusion, both percutaneous US- and EUS-guided biopsies of solid pancreatic lesions are safe and effective; though the diagnostic accuracy of EUS-FNA is inferior to US-CNB/FNA. A tailored pancreatic biopsy should be considered a part of the management algorithm for the diagnosis of solid pancreatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic DiseasesPancreatic NeoplasmsHumansEndoscopic Ultrasound-Guided Fine Needle AspirationPancreasImage-Guided Biopsy

Stichwörter der Autor:innen

BiopsyEndoscopic ultrasoundFine needle aspirationPancreaticUltrasound

Autor:innen und Institutionen

  • Department of Ultrasonography, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang U…
  • Department of Ultrasonography, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Department of Ultrasonography, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Department of Ultrasound, Taizhou Hospital, Taizhou 317000, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chai, W. L., Kuang, X. F., Yu, L., Cheng, C., Jin, X. Y., Zhao, Q. Y., & Jiang, T. A. (2023). Percutaneous ultrasound and endoscopic ultrasound-guided biopsy of solid pancreatic lesions: An analysis of 1074 lesions. Hepatobiliary & Pancreatic Diseases International, 22(3), 302-309. https://doi.org/10.1016/j.hbpd.2022.06.017

Vancouver

Chai WL, Kuang XF, Yu L, Cheng C, Jin XY, Zhao QY, et al. Percutaneous ultrasound and endoscopic ultrasound-guided biopsy of solid pancreatic lesions: An analysis of 1074 lesions. Hepatobiliary & Pancreatic Diseases International. 2023;22(3):302-309. doi:10.1016/j.hbpd.2022.06.017

BibTeX
@article{Chai2023,
  author = {Chai, Wei-Lu and Kuang, Xiu-Feng and Yu, Li and Cheng, Chao and Jin, Xin-Yan and Zhao, Qi-Yu and Jiang, Tian-An},
  title = {Percutaneous ultrasound and endoscopic ultrasound-guided biopsy of solid pancreatic lesions: An analysis of 1074 lesions},
  journal = {Hepatobiliary & Pancreatic Diseases International},
  year = {2023},
  volume = {22},
  number = {3},
  pages = {302--309},
  doi = {10.1016/j.hbpd.2022.06.017}
}
Kostenlos starten →